Royal Bank of Canada’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Buy |
1,112
+564
| +103% | +$507 | ﹤0.01% | 6525 |
|
|
2025
Q1 | $0 | Sell |
548
-2,051
| -79% | – | ﹤0.01% | 6584 |
|
|
2024
Q4 | $27K | Sell |
2,599
-6,736
| -72% | -$70K | ﹤0.01% | 5491 |
|
|
2024
Q3 | $123K | Buy |
9,335
+1,376
| +17% | +$18.1K | ﹤0.01% | 4751 |
|
|
2024
Q2 | $78K | Sell |
7,959
-42,775
| -84% | -$419K | ﹤0.01% | 5032 |
|
|
2024
Q1 | $698K | Buy |
50,734
+45,795
| +927% | +$630K | ﹤0.01% | 3352 |
|
|
2023
Q4 | $84K | Sell |
4,939
-15,139
| -75% | -$257K | ﹤0.01% | 5192 |
|
|
2023
Q3 | $283K | Buy |
+20,078
| New | +$283K | ﹤0.01% | 4030 |
|